Mothers are turning to psilocybin mushrooms in a bid to reclaim their mental health, and new research is shining a light on this evolving trend. In his latest book, Dr. Jim Fadiman explores data from the Mothers of the Mushroom Project, revealing that many moms use microdosing—from occasional journeys to regular microdoses—to combat anxiety, depression, overwhelm, and to boost parenting capacity and personal growth. Meanwhile, Reunion Neuroscience is testing RE104, a psilocybin-like drug, in a clinical trial aimed at offering a new treatment for postpartum depression, with promising progress toward FDA approval. Tracey Tee, founder of Mom’s on Mushrooms, champions these initiatives, emphasizing that this movement isn’t just about psilocybin—it’s about reimagining mental health solutions that empower mothers to trust their intuition and reclaim their power. Read more at the link below.
Learn more about the Reconnect Study here!
Comments